Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health Tbk's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 71.85.
PT Soho Global Health Tbk's Days Inventory for the
three
months ended in Jun. 2026 was 62.53.
PT Soho Global Health Tbk's Days Payable for the
three
months ended in Jun. 2026 was 104.07.
Therefore, PT Soho Global Health Tbk's Cash Conversion Cycle (CCC) for the
three
months ended in Jun. 2026 was 30.31.
PT Soho Global Health Tbk (ISX:SOHO) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
PT Soho Global Health Tbk Cash Conversion Cycle Related Terms
PT Soho Global Health Tbk Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk Cash Conversion Cycle Chart
ISX:SOHO vs MCK, COR, CAH: Cash Conversion Cycle Comparison
For the Medical Distribution subindustry, PT Soho Global Health Tbk's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk Cash Conversion Cycle vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's Cash Conversion Cycle falls into.
PT Soho Global Health Tbk Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
PT Soho Global Health Tbk's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk (ISX:SOHO) has a Cash Conversion Cycle of 30.31 as of Jun. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on PT Soho Global Health Tbk and its competitors.
Is PT Soho Global Health Tbk's Cash Conversion Cycle too high?
PT Soho Global Health Tbk's current Cash Conversion Cycle is 30.31. The Medical Distribution industry median Cash Conversion Cycle is 56.57. PT Soho Global Health Tbk's value of 30.31 is 46.4% below this industry median. Overall, PT Soho Global Health Tbk has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Cash Conversion Cycle compare to MCK and COR?
PT Soho Global Health Tbk's Cash Conversion Cycle of 30.31 can be compared against companies in the Medical Distribution industry. The industry median Cash Conversion Cycle is 56.57. PT Soho Global Health Tbk's value of 30.31 is 46.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Distribution company?
The median Cash Conversion Cycle among Medical Distribution companies is 56.57, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current Cash Conversion Cycle of 30.31 is 46.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median Cash Conversion Cycle is 56.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current Cash Conversion Cycle is 30.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Cash Conversion Cycle is 30.31 and 46.4% below the Medical Distribution industry median of 56.57. PT Soho Global Health Tbk's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Cash Conversion Cycle is 30.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
Cash Conversion Cycle: 30.31
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 46.4% below the Medical Distribution median
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
85GF Score
Get the complete analysis for ISX:SOHO
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
